Abstract:Endometriosis is a chronic, inflammatory gynecological condition defined by the presence of endometrial-like epithelium and/or stroma outside of the uterus ([Fig. 1]). Endometriosis exists on a spectrum of presentations and can be further classified by location into superficial peritoneal (lesions involving the peritoneal surface), ovarian (formation of endometriomas or "chocolate cysts" on the ovaries typically containing ectopic tissue and bloody fluid), deep (nodular implantation of tissue into the peritoneal surface with associate fibrosis), extra-abdominal (outside the abdomen), and iatrogenic (dissemination of endometrium following surgery).[1] The clinical presentation of endometriosis is variable, and depends on the subtype of endometriosis and location(s) of involvement. While up to 20 to 25% of patients are asymptomatic, common clinical features include chronic pelvic pain which worsens prior to the onset of menses, dysmenorrhea, dyspareunia, and infertility.[2] [3] Despite its strong link to infertility in women, the pathophysiology of endometriosis remains poorly understood. Postulated to be a combination of the development of a pro-invasive inflammatory milieu by endometrial cells and retrograde flux of endometrial tissue through the fallopian tubes into and beyond the endometrial cavity, there remains a lack of consensus regarding the etiology of endometriosis.[1] Furthermore, this explanation does not account for the disparity between women with retrograde flow, seen in up to 90% of women, and the eventual development of endometriosis.[4] With studies approximating the prevalence of endometriosis between 25 and 50% in infertile women, optimization of obstetric outcomes is a priority among patients seeking treatment.[3] While surgical outcomes typically improve symptoms and increase the pregnancy rate, they come with appreciable risk of damage to the ovaries and diminished ovarian reserve.[5] Given the significant morbidity and impairment in fertility associated with endometriosis, its examination as a clinical entity, as well as the limitations and advantages in its treatment, is warranted. Article published online: 24 January 2024 © 2023. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Endometriosis: Cell Death and Cell Signaling Machinery

Apoptosis and Endometriosis

An Update on the Multifaceted Role of NF-kappaB in Endometriosis

Regulated Cell Death in Endometriosis

Molecular and Cellular Pathogenesis of Endometriosis

Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions

Mitogen Activated Protein Kinases Signaling Pathway and Endometriosis

Endometriosis in the era of precision medicine and impact on sexual and reproductive health across the lifespan and in diverse populations

Pathogenesis of Endometriosis and Endometriosis-Associated Cancers

Future Biological Perspectives for Diagnosis and Treatment

Molecular mechanism of autophagy and apoptosis in endometriosis: Current understanding and future research directions

Endometriosis: A Malignant Fingerprint

Endometriosis: An Overview

Endometriosis: Cellular and Molecular Mechanisms Leading to Fibrosis

The role of endoplasmic reticulum stress in endometriosis

Single-cell transcriptomic analysis of endometriosis

Molecular Biology of Endometriosis: From Aromatase to Genomic Abnormalities

Endometriosis: A Comprehensive Exploration of Inflammatory Mechanisms and Fertility Implications

“Endometriosis”: A Neuro-Etiologic Framework for Its Causes and Consequences

Endometriosis: Evaluation and Treatment

Pathogenesis Based Diagnosis and Treatment of Endometriosis